The objective of this study was to create a clinically useful tool for individualized prediction of seizure outcomes following antiepileptic drug withdrawal after pediatric epilepsy surgery. We used data from the European retrospective TimeToStop study, which included 766 children from 15 centers, to perform a proportional hazard regression analysis. The 2 outcome measures were seizure recurrence and seizure freedom in the last year of follow-up. Prognostic factors were identified through systematic review of the literature. The strongest predictors for each outcome were selected through backward selection, after which nomograms were cre- 
| INTRODUCTION
After successful pediatric epilepsy surgery, a pressing question for many patients and their caretakers is whether and when to reduce antiepileptic drugs (AEDs). Being able to discontinue drugs is the ultimate proof of successful epilepsy surgery. Stopping medication will prevent further drug adverse effects and may improve cognitive domains, such as psychomotor speed, executive functions and IQ. [1] [2] [3] [4] The decision to withdraw AEDs is partially based on an assessment of the risk of seizure recurrence. Predictors of seizure recurrence on a group level have been identified in previous publications, [5] [6] [7] [8] [9] [10] but prediction of relapse is not yet possible for an individual patient. The TimeToStop study previously showed that early withdrawal unmasks surgical failure but is not related to long-term seizure outcomes. 6 This conclusion was based on multivariable survival analysis but did not yet enable individualized prediction of AED withdrawal outcomes. We now use the TimeToStop data to create nomograms and a web-based tool to enable estimation of individual risks, analogous to the recently developed prediction models for nonsurgical patients.
11
*Members of the TimeToStop study group are listed at the end of the paper.
| METHODS
Data of 766 patients were available from the TimeToStop study; for an extensive description of data collection and definitions we refer to the earlier report. 6 In short, patients were identified retrospectively within 15 pediatric epilepsy surgery centers in Europe. Patients were included if they had epilepsy surgery between 2000 and 2008, were younger than 18 years at surgery, had at least 1 year of follow-up after surgery, and if postoperative AED withdrawal was initiated. Data were collected on clinical, surgical, and seizure outcome parameters. Two outcome measures were used: first, seizure recurrence after start of AED withdrawal and second, the seizure status at final follow-up, with favorable outcome being defined as seizure freedom (including freedom from auras) for at least 1 year at final follow-up. We decided not to model for 'cure" (seizure and AED freedom at final follow-up), which was the third outcome measure in the original TimeToStop study, because the decision to completely discontinue medication is dependent on the policy of the individual physician, and these policies may change over time or may already have changed. A systematic review on risk factors of postoperative AED withdrawal previously identified 12 potential factors predictive of outcome, 12 listed in Table S1 . These factors were all available in the TimeToStop dataset.
Missing data were analyzed and imputed through multiple imputations using predictive mean matching. Heterogeneity between centers was tested, and when present, random-effects modeling was used. Assumptions were tested: if the linearity assumption was violated, restricted cubic splines with 3 knots were used. Proportional hazard (Cox) regression analysis was used to account for different follow-up duration. For seizure recurrence, censoring time was the time to seizure recurrence. For seizure freedom, censoring time was time to seizure recurrence, only for those with unfavorable outcome. All patients with favorable outcome were censored at maximum follow-up. To create a useful set of predictors, the Akaike Information Criterion was used for backward selection of strongest predictors.
For the purpose of the prognostic models, variables with 3 or 4 items of which only 1 differed significantly from the reference category were dichotomized so that the nonsignificant categories were collapsed with the reference category. This was done for magnetic resonance imaging (MRI; multifocal MRI abnormalities vs focal MRI abnormality and normal MRI), for prewithdrawal electroencephalography (EEG; interictal epileptiform discharges vs no such discharges or no EEG performed), and for completeness of resection (incomplete resection of the anatomical lesion vs complete resection or completeness not determined). Within the nomograms, risk calculation of seizure recurrence was enabled for 2 and 5 years after start of AED withdrawal, and calculation of eventual seizure freedom was set at 6 years. We chose 6 years after start of AED withdrawal to model the chance of eventual "long-term" seizure freedom, creating a 1-year longer interval than the latest calculated 5-year relapse risk, as this intuitively allows for extra time to regain seizure freedom after restart of medication if a late recurrence has occurred.
Internal validation was accomplished by determining the concordance statistic for each model, corrected for overfitting using 200 bootstrap samples. Plotting of the predicted probabilities against observed proportions of the outcomes was done to visually assess calibration of the separate models. Internal-external cross-validation was performed by iteratively removing 1 of the 4 largest centers, refitting the model on the remaining data, and externally validating on the excluded dataset.
Analyses were performed with R Statistical software version 3.3.2, using the packages "MICE," "coxme," and "rms." Ethics approval was obtained for the original TimeToStop study.
| RESULTS
One percent of data was missing and imputed (Table S2) . The seizure outcomes after AED withdrawal were the following: seizure recurrence in 95/766 patients (12%) and seizure freedom in the last year of follow-up in 733/760 patients (96%). Median follow-up after start of AED withdrawal was 39 months (interquartile range [IQR] 21-67 months) (Table S3 ). Univariable relations between potential predictors and outcomes are shown in Table S4 .
One of the parameters, the presence of postoperative seizures (excluding seizures in the first 2 postoperative weeks), was not included in the analysis because none of the 13 cases experienced seizure recurrence, and consequently no parameters could be estimated. The median time to reduction (start tapering of the first drug) for these patients was 24 months (IQR 19-37), compared to 13 months (IQR 6-24) in the patients without postoperative seizures. AED status at final follow-up was known for 11 of these: 6 patients successfully discontinued AEDs and 5 were still using AEDs.
The strongest predictors were selected through backward selection, resulting in 2 models. The proportional hazards assumption was not violated. Table 1 shows the outcome of multivariable Cox regression of these models. Figure 1 is the visualization of the models in the form of nomograms. The predictors for each model and model parameters are listed below. Heterogeneity between centers was low, and a regular (fixed-effects) Cox regression was
performed. The nomograms were converted to a web-based tool, accessible at www.EpilepsyPredictionTools.info/ttswith drawal. Calibration of the models is visualized in Figures 1C  and D .
Factors predicting seizure recurrence were the following: (higher) age at withdrawal, (shorter) time to AED reduction (start tapering of the first AED), multifocal MRI abnormalities, interictal epileptiform discharges on EEG, and incomplete resection of the anatomical lesion (Table 1, Figure 1 ); these factors combined into a prediction model had an adjusted concordance-statistic of 0.68 (95% CI 0.67-0.69). Internal-external cross-validation shows variation of the adjusted c-statistic between 0.61 and 0.69, with wider confidence intervals ( Table 2) .
Factors predicting seizure freedom at final follow-up were the following: seizure frequency before surgery, (lower) number of AEDs used at time of surgery, and complete resection of the anatomical lesion (Table 1, Figure 1) ; these factors combined into a prediction model had an adjusted concordance-statistic of 0.73 (95% CI
| DISCUSSION
We developed a prognostic tool to predict the seizure outcome after AED withdrawal in children who became seizure-free through epilepsy surgery, based on preselected factors that were identified through systematic review of the literature. The nomograms and the web-based tool, developed on a dataset from 766 children, are clinically useful when considering AED withdrawal in an individual patient. The predicted outcomes can serve as a basis to counsel children and caregivers when balancing the risks and benefits of AED withdrawal. The selected predictors differ between the 2 models. Of interest, 4 predictors of seizure recurrence were not predictive of eventual seizure outcome: the timing of AED withdrawal-as revealed in the original TimeToStop study report 6 -the findings of preoperative MRI, the age at withdrawal, and postoperative Multivariable models with strongest predictors for seizure recurrence and seizure freedom at last follow-up. Categorical variables with 3 or 4 items of which only 1 was significantly different from the reference category were dichotomized, so that the nonsignificant categories were collapsed with the reference category. The random effects measure of heterogeneity can be interpreted as the hazard rate between 2 equally sized prognostic groups from 2 different cohorts. The values indicate relatively low heterogeneity.
a Not linearly modeled, restricted cubic splines used with 3 knots. For the effect size, see Figure 1 .
e30 | EEG abnormalities. Two factors were related only to eventual seizure outcome: the preoperative seizure frequency had a U-shaped relation with seizure outcome, with the lowest and highest seizure frequencies related to lower chances of eventual seizure freedom, and the number of AEDs before surgery, which showed a linear relation with the outcome. The only factor predictive of both outcomes was the completeness of resection: incomplete resection of the anatomical lesion increased the hazard of seizure recurrence by a factor of 2.5 and decreased the hazard of eventual seizure freedom by a factor of 4.
Model performance in terms of discrimination was best for predicting eventual seizure freedom, with an adjusted cstatistic of 0.73. The calibration plot for this model shows that it can accurately identify a small proportion with increased risk, where most patients have a predicted chance between 95% and 100% of being seizure-free for at least 1 year at an average follow-up duration of 6 years after start of AED withdrawal. For predicting seizure recurrence, the adjusted c-statistic of 0.68 shows reasonable discriminatory ability of the model.
The current analysis has several limitations. First, although the analysis was performed on a Europe-wide multicenter cohort and bootstrap-samples were used to correct for overfitting, model performance should be tested in an external validation cohort, because the data were collected retrospectively. Second, one of the preselected potential predictors, "postoperative seizures," was not tested because none of the patients with this factor experienced seizure relapse. Although no parameters could be estimated, none of these 13 patients relapsed and 6 of 11 patients (55%) were successful at discontinuing AEDs, which is similar to the 48% in the complete cohort. Therefore, the current data do not indicate an increased risk for patients with postoperative seizures, once it has been decided to withdraw AEDs. However, the time to reduction was almost twice as long for these patients, indicating that they had a substantial longer period of seizure freedom after the initial postsurgical relapse before reduction of AEDs. Finally, it is important to realize that postoperative seizure relapse risk has never been compared between patients who do, and those who do not, withdraw medication, in a prospective randomized manner. Our data, and all cohort studies reporting on postwithdrawal relapse rates, included only a selection of patients for whom the treating physician deemed it safe to start AED withdrawal. It cannot be excluded that recurrence rates, predicted by the current model, are somewhat higher when applied in a total cohort of unselected children who underwent epilepsy surgery. Therefore, the risk predictor is most reliably applied in patients in whom physicians already consider withdrawal of medication but want to balance its risks and benefits to better counsel the individual patient and his or her caregivers.
In conclusion, 2 prognostic models with moderate to good discriminative performance were created and converted to a clinically useful tool to predict the individual risk of seizure recurrence, and eventual seizure freedom, for children after epilepsy surgery.
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